Cansartan-Mepha 16, Tabletten - 28 Tablette(n) Swissmedic Key 60929011 Registration Holder Mepha Pharma AG Name Cansartan-Mepha 16, Tabletten Date of registration 30.11.2010 Original/Generic Generic Introduction of Sequence 30.11.2010 ATC-Classification Candesartan (C09CA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.10. Show package size 28 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 8.08 Limitation No Deductible 10 % Consumer price 25.25 Feedback FB Daily cost GTIN 7680609290113 Medication Code Synthetika Pharmacode 5429653 Disponibility
Composition candesartanum cilexetilum 16 mg, maydis amylum, lactosum monohydricum 121.8 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.48 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 16 mg
BAG: Active Agent Dose Candesartanum Cilexetil 16 mg
Inactive agents Dose Carmellosum Natricum Conexum Hydroxypropylcellulosum Lactose Monohydrate 121.8 mg Magnesii Stearas Maydis Amylum Pro Compresso Triethylis Citras
Source Data was imported : 05.08.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
